{"transactions":[{"id":750809,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41618,"kind":"person","name":"Yi Qingqing","position":1,"cik":"0001662556","reported_name":"Yi Qingqing","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2026-06-03T20:10:26.000Z","date":"2026-06-01","kind":"sale","planned":false,"acquired":false,"shares":235,"price":279.13,"value":65595.55,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of restricted share units (\"RSUs\") previously granted to the Reporting Person. The RSUs shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000919574-26-003800","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000091957426003800/ownership.xml","form_type":"4"}},{"id":1112849,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41618,"kind":"person","name":"Yi Qingqing","position":1,"cik":"0001662556","reported_name":"Yi Qingqing","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-06-12T20:19:09.000Z","date":"2025-06-10","kind":"other","planned":false,"acquired":false,"shares":29614,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a transfer of shares by Qingqing Yi (\"Mr. Yi\") to certain funds managed by his employer and for whose benefit he was holding the shares. Mr. Yi expressly disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any."}],"balance_after":27326,"source":{"system":"sec-edgar","filing":"0000902664-25-002711","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000090266425002711/ownership.xml","form_type":"4"}},{"id":1134774,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41618,"kind":"person","name":"Yi Qingqing","position":1,"cik":"0001662556","reported_name":"Yi Qingqing","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-05-23T20:05:13.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":22750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each ADS represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each ADS represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":22750,"derivative":{"exercise_price":18.19,"expiration_date":"2035-05-20","underlying":"Ordinary Shares","underlying_shares":22750},"source":{"system":"sec-edgar","filing":"0000902664-25-002529","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000090266425002529/ownership.xml","form_type":"4"}},{"id":1134773,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41618,"kind":"person","name":"Yi Qingqing","position":1,"cik":"0001662556","reported_name":"Yi Qingqing","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-23T20:05:13.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":10985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents securities underlying restricted share units (\"RSUs\"). All RSUs will vest upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":56940,"source":{"system":"sec-edgar","filing":"0000902664-25-002529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000090266425002529/ownership.xml","form_type":"4"}},{"id":1486082,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41618,"kind":"person","name":"Yi Qingqing","position":1,"cik":"0001662556","reported_name":"Yi Qingqing","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2024-06-07T20:31:17.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":34151,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each ADS represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each ADS represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":34151,"derivative":{"exercise_price":12.23,"expiration_date":"2034-06-04","underlying":"Ordinary Shares","underlying_shares":34151},"source":{"system":"sec-edgar","filing":"0000902664-24-004124","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000090266424004124/ownership.xml","form_type":"4"}},{"id":1486081,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41618,"kind":"person","name":"Yi Qingqing","position":1,"cik":"0001662556","reported_name":"Yi Qingqing","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-06-07T20:31:17.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":16341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents securities underlying restricted share units (\"RSUs\"). All RSUs will vest upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":45955,"source":{"system":"sec-edgar","filing":"0000902664-24-004124","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000090266424004124/ownership.xml","form_type":"4"}},{"id":1848694,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41618,"kind":"person","name":"Yi Qingqing","position":1,"cik":"0001662556","reported_name":"Yi Qingqing","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2023-06-20T20:30:22.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":26975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each ADS represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each ADS represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":26975,"derivative":{"exercise_price":16.41,"expiration_date":"2033-06-14","underlying":"Ordinary Shares","underlying_shares":26975},"source":{"system":"sec-edgar","filing":"0000902664-23-003641","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000090266423003641/ownership.xml","form_type":"4"}},{"id":1848693,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41618,"kind":"person","name":"Yi Qingqing","position":1,"cik":"0001662556","reported_name":"Yi Qingqing","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-20T20:30:22.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":12922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying RSUs. All RSUs will vest upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":29614,"source":{"system":"sec-edgar","filing":"0000902664-23-003641","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000090266423003641/ownership.xml","form_type":"4"}},{"id":2174660,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41618,"kind":"person","name":"Yi Qingqing","position":1,"cik":"0001662556","reported_name":"Yi Qingqing","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-08-24T20:15:58.000Z","date":"2022-08-22","kind":"other","acquired":false,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents a transfer of shares by Qingqing Yi (\"Mr. Yi\") to certain funds managed by his employer and for whose benefit he was holding the shares. Mr. Yi expressly disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a transfer of shares by Qingqing Yi (\"Mr. Yi\") to certain funds managed by his employer and for whose benefit he was holding the shares. Mr. Yi expressly disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any."}],"balance_after":16692,"source":{"system":"sec-edgar","filing":"0000902664-22-004101","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000090266422004101/ownership.xml","form_type":"4"}},{"id":2221749,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41618,"kind":"person","name":"Yi Qingqing","position":1,"cik":"0001662556","reported_name":"Yi Qingqing","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2022-06-24T20:15:34.000Z","date":"2022-06-22","kind":"grant","acquired":false,"shares":34645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each ADS represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each ADS represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":34645,"derivative":{"exercise_price":11.98,"expiration_date":"2032-06-21","underlying":"Ordinary Shares","underlying_shares":34645},"source":{"system":"sec-edgar","filing":"0000902664-22-003398","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000090266422003398/ownership.xml","form_type":"4"}},{"id":2221748,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41618,"kind":"person","name":"Yi Qingqing","position":1,"cik":"0001662556","reported_name":"Yi Qingqing","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-06-24T20:15:34.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":16692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying RSUs. All RSUs will vest upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":24492,"source":{"system":"sec-edgar","filing":"0000902664-22-003398","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000090266422003398/ownership.xml","form_type":"4"}},{"id":2655481,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41618,"kind":"person","name":"Yi Qingqing","position":1,"cik":"0001662556","reported_name":"Yi Qingqing","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2021-06-24T16:26:32.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":17498,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each ADS represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each ADS represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These securities vest over a four-year period as follows: 25% on the first anniversary of June 16, 2021 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested shares are subject to accelerated vesting upon change of control or certain termination events."}],"balance_after":17498,"derivative":{"exercise_price":26.53,"expiration_date":"2031-06-15","underlying":"Ordinary Shares","underlying_shares":17498},"source":{"system":"sec-edgar","filing":"0000902664-21-003255","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000090266421003255/ownership.xml","form_type":"4"}},{"id":2655480,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41618,"kind":"person","name":"Yi Qingqing","position":1,"cik":"0001662556","reported_name":"Yi Qingqing","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-06-24T16:26:32.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":7800,"source":{"system":"sec-edgar","filing":"0000902664-21-003255","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000090266421003255/ownership.xml","form_type":"4"}},{"id":3103882,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41618,"kind":"person","name":"Yi Qingqing","position":1,"cik":"0001662556","reported_name":"Yi Qingqing","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2020-06-19T20:15:27.000Z","date":"2020-06-17","kind":"grant","acquired":false,"shares":45383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of the issuer's American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of the issuer's American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of the issuer's American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of the issuer's American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."}],"balance_after":45383,"derivative":{"exercise_price":13.42,"expiration_date":"2030-06-16","underlying":"Ordinary Shares","underlying_shares":45383},"source":{"system":"sec-edgar","filing":"0000902664-20-002459","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000090266420002459/ownership.xml","form_type":"4"}},{"id":3485629,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41618,"kind":"person","name":"Yi Qingqing","position":1,"cik":"0001662556","reported_name":"Yi Qingqing","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-06-18T14:41:00.000Z","date":"2019-06-17","kind":"other","acquired":false,"shares":9282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a transfer of shares by Qingqing Yi (\"Mr. Yi\") to certain funds managed by his employer and for whose benefit he was holding the shares. Mr. Yi expressly disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any."},{"field":"shares","element":"transactionShares","label":"F2","text":"The 9,290 restricted share units (\"RSUs\") previously reported by Mr. Yi on June 8, 2018 were revised to 9,282 RSUs to be divisible by 13, as each of the Issuer's American Depositary Shares represents 13 Ordinary Shares. The Share Options previously reported by Mr. Yi on the same date were revised to 17,433 Share Options for the same reason."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000902664-19-002801","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000090266419002801/ownership.xml","form_type":"4"}},{"id":3493697,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41618,"kind":"person","name":"Yi Qingqing","position":1,"cik":"0001662556","reported_name":"Yi Qingqing","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2019-06-11T12:25:45.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":64610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."}],"balance_after":64610,"derivative":{"exercise_price":9.23,"expiration_date":"2029-06-04","underlying":"Ordinary Shares","underlying_shares":64610},"source":{"system":"sec-edgar","filing":"0000902664-19-002708","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000090266419002708/ownership.xml","form_type":"4"}},{"id":3900177,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41618,"kind":"person","name":"Yi Qingqing","position":1,"cik":"0001662556","reported_name":"Yi Qingqing","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2018-06-08T22:42:23.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":17442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."}],"balance_after":17442,"derivative":{"exercise_price":16.15,"expiration_date":"2028-06-05","underlying":"Ordinary Shares","underlying_shares":17442},"source":{"system":"sec-edgar","filing":"0000902664-18-002540","document":"p18-1312form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000090266418002540/p18-1312form4.xml","form_type":"4"}},{"id":3900176,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41618,"kind":"person","name":"Yi Qingqing","position":1,"cik":"0001662556","reported_name":"Yi Qingqing","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-06-08T22:42:23.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":9290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units (\"RSUs\"). All securities will vest upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":9290,"source":{"system":"sec-edgar","filing":"0000902664-18-002540","document":"p18-1312form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000090266418002540/p18-1312form4.xml","form_type":"4"}},{"id":4347815,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41618,"kind":"person","name":"Yi Qingqing","position":1,"cik":"0001662556","reported_name":"Yi Qingqing","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2017-04-21T21:05:30.000Z","date":"2017-04-19","kind":"grant","acquired":true,"shares":199992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In ordinary shares. One American Depositary Share represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F1","text":"In ordinary shares. One American Depositary Share represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall become exercisable in equal installments on the first, second and third anniversary of the grant date and shall become exercisable in full on the date of the third annual meeting of shareholders following the grant date. All vesting shall cease if the Reporting Person resigns from the Issuer's board of directors or otherwise ceases to serve as a director, unless the Issuer's board of directors determines that the circumstances warrant the continuation of vesting."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"In ordinary shares. One American Depositary Share represents 13 ordinary shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In ordinary shares. One American Depositary Share represents 13 ordinary shares."}],"balance_after":199992,"derivative":{"exercise_price":2.84,"expiration_date":"2027-04-18","underlying":"Ordinary Shares","underlying_shares":199992},"source":{"system":"sec-edgar","filing":"0000902664-17-002041","document":"p17-1045form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000090266417002041/p17-1045form4.xml","form_type":"4"}}]}